Guardian Pharmacy Services Inc. Class A (GRDN)
NYSE: GRDNConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 40.68 0.00%
GRDN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.58B
- P/E (TTM)
- 39.50
- Forward P/E
- 28.36
- EPS (TTM)
- $1.03
- Dividend yield
- None
- 52-week range
- 23.14 – 48.33
- Day range
- 40.40 – 41.98
- Volume / Avg
- 388.31K / 473.34K
- Beta
- —
- Shares outstanding
- 63.32M
52-week range
GRDN stock today
Shares of Guardian Pharmacy Services (GRDN) finished lower on Oct 7 at $40.68, a drop of 1.26% or $0.52 per share, versus the S&P 500's 0.22% decline. Shares are 15.8% below their 52-week high of $48.33, set on Sep 16, 2026 and 75.8% above the 52-week low of $23.14, in the middle of the past year's range. GRDN is up 35.2% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 71.4%.
Guardian Pharmacy Services trades at 39.5x its trailing twelve-month earnings per share of $1.03. Its forward P/E of 28.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Guardian Pharmacy Services
Company profileGuardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.
- Sector
- Consumer Staples
- Industry
- Retail-Drug Stores and Proprietary Stores
- CEO
- Mr. Fred P. Burke
- Headquarters
- Atlanta, GA
- Employees
- 3,600
- IPO year
- 2024
- Website
- guardianpharmacy.com
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$49.86+22.57%
- Strong buy 1
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Guardian Pharmacy Services peers
Consumer Staples sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PETSPetMed Express Inc. | 1.28 | -2.29% | $27.75M | vs GRDN |
| YI111 Inc. ADR | 3.15 | +1.94% | $27.71M | vs GRDN |
| RDGTRidgetech Inc. | 0.9789 | +5.26% | $3.55M | vs GRDN |
| CVSCVS Health Corporation | 87.95 | +1.76% | $112.49B | vs GRDN |
Indexes, lists and sector
Largest Consumer Staples stocks
Guardian Pharmacy Services stock FAQ
What is Guardian Pharmacy Services's stock price today?
GRDN last traded at $40.68 as of Oct 7, 4:00 PM EDT, down 1.26% on the day. Prices are delayed at least 15 minutes.
What is GRDN's P/E ratio?
GRDN trades at a trailing P/E ratio of 39.50 and a forward P/E of 28.36.
Who is Guardian Pharmacy Services's CEO?
Mr. Fred P. Burke is the chief executive officer of Guardian Pharmacy Services Inc. Class A, which has about 3,600 employees.
What is the GRDN 52-week high?
The 52-week high for GRDN is $48.33 and the 52-week low is $23.14. The stock is currently 15.8% below its high.